Cargando…
COVID‐19‐associated pulmonary aspergillosis in ICU patients in a German reference centre: Phenotypic and molecular characterisation of Aspergillus fumigatus isolates
BACKGROUND: COVID‐19‐associated invasive pulmonary aspergillosis (CAPA) is associated with increased mortality. Cases of CAPA caused by azole‐resistant Aspergillus fumigatus strains have been reported. OBJECTIVES: To analyse the twelve‐month CAPA prevalence in a German tertiary care hospital and to...
Autores principales: | Kirchhoff, Lisa, Braun, Lukas Miles, Schmidt, Dirk, Dittmer, Silke, Dedy, Jutta, Herbstreit, Frank, Stauf, Raphael, Steckel, Nina Kristin, Buer, Jan, Rath, Peter‐Michael, Steinmann, Joerg, Verhasselt, Hedda Luise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115305/ https://www.ncbi.nlm.nih.gov/pubmed/35138651 http://dx.doi.org/10.1111/myc.13430 |
Ejemplares similares
-
Prevalence of COVID-19 Associated Mucormycosis in a German Tertiary Care Hospital
por: Scharmann, Ulrike, et al.
Publicado: (2022) -
COVID-19 Co-infection with Legionella pneumophila in 2 Tertiary-Care Hospitals, Germany
por: Verhasselt, Hedda L., et al.
Publicado: (2021) -
Microbiological Non-Culture-Based Methods for Diagnosing Invasive Pulmonary Aspergillosis in ICU Patients
por: Scharmann, Ulrike, et al.
Publicado: (2023) -
In Vitro and In Vivo Activity of Luliconazole (NND-502) against Planktonic Cells and Biofilms of Azole Resistant Aspergillus fumigatus
por: Furnica, Dan-Tiberiu, et al.
Publicado: (2022) -
Antibacterial Activity of the Novel Drug Gepotidacin against Stenotrophomonas maltophilia—An In Vitro and In Vivo Study
por: Sanders, Maike Isabell, et al.
Publicado: (2022)